Literature DB >> 21880041

Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.

Lacey Johnson1, Kelly M Winter, Tanja Hartkopf-Theis, Samantha Reid, Matthew Kwok, Denese C Marks.   

Abstract

BACKGROUND: Collecting apheresis platelets (PLTs) into additive solution has many potential benefits. The new Trima software (Version 6.0, CaridianBCT) allows automated addition of PLT additive solution (PAS) after collection, compared to Trima Version 5.1, which only collects PLTs into plasma. The aim of this study was to compare PLT quality during extended storage, after collection with the different Trima systems. STUDY DESIGN AND METHODS: Apheresis PLTs were collected using both Trima Accel apheresis systems. The test PLT units (n = 12) were collected using the new Trima Version 6.0 into PLT AS (PAS-IIIM), while the control units (n = 8) were collected into autologous plasma using Trima Version 5.1. All units were stored for 9 days, and in vitro cell quality variables were evaluated during this time.
RESULTS: PLTs collected in PAS-IIIM maintained a stable pH between 7.2 and 7.4, whereas plasma-stored apheresis units exhibited significantly increased acidity during storage, due to lactate accumulation and bicarbonate exhaustion. Plasma-stored PLTs also demonstrated a more rapid consumption of glucose. However, there was little difference in PLT activation or cytokine secretion between PAS-IIIM and control PLTs.
CONCLUSION: These data indicate that apheresis PLT concentrates collected in PAS-IIIM, using Trima Version 6.0 software, maintained acceptable PLT metabolic and cellular characteristics until Day 9 of storage.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880041     DOI: 10.1111/j.1537-2995.2011.03314.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  In vitro Quality of Platelets with Low Plasma Carryover Treated with Ultraviolet C Light for Pathogen Inactivation.

Authors:  Lacey Johnson; Ryan Hyland; Shereen Tan; Frank Tolksdorf; Chryslain Sumian; Axel Seltsam; Denese Marks
Journal:  Transfus Med Hemother       Date:  2015-11-05       Impact factor: 3.747

2.  Treatment of Platelet Concentrates with the Mirasol Pathogen Inactivation System Modulates Platelet Oxidative Stress and NF-κB Activation.

Authors:  Lacey Johnson; Denese Marks
Journal:  Transfus Med Hemother       Date:  2015-05-07       Impact factor: 3.747

Review 3.  Quality Assessment of Established and Emerging Blood Components for Transfusion.

Authors:  Jason P Acker; Denese C Marks; William P Sheffield
Journal:  J Blood Transfus       Date:  2016-12-14

4.  Adding to platelet safety and life: Platelet additive solutions.

Authors:  Ankit Mathur; Narasimha Swamy; Samrat Thapa; Santanu Chakraborthy; Latha Jagannathan
Journal:  Asian J Transfus Sci       Date:  2018 Jul-Dec

Review 5.  Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.

Authors:  Fumiya Hirayama
Journal:  Br J Haematol       Date:  2012-12-06       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.